Company Profile

Healthsim Inc (AKA: Healthsim LLC)
Profile last edited on: 5/21/18      CAGE: 4LBU3      UEI:

Business Identifier: Prevention science products
Year Founded
1997
First Award
1998
Latest Award
2015
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

101 West 23rd Street Suite 525
New York, NY 10011
   (888) 887-4957
   questions@healthsim.com
   www.healthsim.com
Location: Single
Congr. District: 10
County: New York

Public Profile

Healthsim Inc specializes in the research and development of prevention science products. The program's curriculum incorporates the components of primary prevention efforts that have been shown to be efficacious in preventing initiation to drug use, such as drug refusal skills training, general decision-making skills training, and social skills training, which are presented in the context of both Computer Assisted Instruction (CAI) and video-based simulation technologies. HealthSim believes that this approach will promote the increased adoption of prevention science, as it is designed to be efficacious, cost-effective, easy to deploy and able to be applied with fidelity. This program is designed to promote well-known "protective factors" (such as social skills, decision-making skills, and self-efficacy). It is also designed to target all forms of drug use, especially, cigarettes, alcohol, marijuana, but also other illicit drugs

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2015 2 NIH $1,034,022
Project Title: Computer-Based Prescription Opioid Abuse Prevention for Adolescents
2007 2 NIH $850,001
Project Title: Expanding Computer-Based Drug Abuse Prevention
2004 2 NIH $599,919
Project Title: Applying Web Technology to Buprenorphine Treatment
2001 2 NIH $906,218
Project Title: Drug Abuse Prevention--Computer Technology Application

Key People / Management

  Warren K Bickel -- CEO

  Lisa A Marsch -- President

  Michael Grabinski -- CTO

Company News

There are no news available.